https://www.selleckchem.com/pr....oducts/valemetostat-
Most women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention risk-reducing salpingo-oophorectomy (RRSO). Because the fallopian tubes play a key role in ovarian cancer pathogenesis, salpingectomy with delayed oophorectomy may be a novel risk-reducing strategy with benefits of delaying menopause. To compare menopause-related quality of life after risk-reducing salpingectomy (RRS) with delayed oophorectomy with R
पसंद करना
टिप्पणी
शेयर करना
